Research Article Open Access

Epigenetic Mechanisms in Hepatitis C Virus-Associated Hepatocellular Carcinoma: A Potential New Link Between Stem Cells, Virology and Cancer

Qinghua Feng1, Sajida Hassan1, Trina Das1, Jianfei Huang2, Zhenqing Feng3 and David Gretch1
  • 1 University of Washington, United States
  • 2 Affiliated Hospital of University of Nantong, China
  • 3 Nanjing Medical University, China

Abstract

Recent studies suggest that epigenetic mechanisms are not only essential for the dynamic transcriptional regulation in embryonic and somatic stem cells, but are also actively involved in tumorigenesis: genes important for pluripotency are epigenetically regulated and aberrant epigenetic changes have been detected in virtually all human malignancies studied, including Hepatocellular Carcinoma (HCC). Infection with Hepatitis C Virus (HCV) is a major risk factor for the development of HCC. Despite the fact that HCV is a RNA virus without a DNA intermediate, recent studies demonstrate that HCV viral proteins may actively participate in epigenetic regulation of hepatic cancer stem cell phenotypes and induce HCC-specific epigenetic changes. Identification of host epigenetic alterations induced by HCV infection and epigenetic differences between hepatic cancer stem cells and the bulk non-tumorigenic cancer cells, may yield potential biomarkers for early detection, as well as therapeutic targets for HCV associated HCC.

Current Research in Medicine
Volume 4 No. 1, 2013, 21-35

DOI: https://doi.org/10.3844/amjsp.2013.21.35

Submitted On: 18 September 2012 Published On: 12 March 2013

How to Cite: Feng, Q., Hassan, S., Das, T., Huang, J., Feng, Z. & Gretch, D. (2013). Epigenetic Mechanisms in Hepatitis C Virus-Associated Hepatocellular Carcinoma: A Potential New Link Between Stem Cells, Virology and Cancer. Current Research in Medicine, 4(1), 21-35. https://doi.org/10.3844/amjsp.2013.21.35

  • 4,250 Views
  • 3,387 Downloads
  • 3 Citations

Download

Keywords

  • HCV
  • Epigenetics
  • Epithelial Mesenchymal Transition (EMT)
  • Cancer Stem Cells (CSC)